Drug Trial Radar · NCT03478462
Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Apr 30, 2019
Primary completion
Jun 30, 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Cellectar Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 27, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and recurrent or refractory malignant brain tumors for which there are no standard treatment options with curative potential.
Conditions
- Pediatric Solid Tumor
- Pediatric Lymphoma
- Pediatric Brain Tumor
- DIPG
- Neuroblastoma
- Ewing Sarcoma
- Rhabdomyosarcoma
- Osteosarcoma
Interventions
CLR 131Drug
IV dose of CLR 131, increased/decreased by dose level; single or fractionated dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with dose limiting toxicities (DLT)Time frame: up to 64 days
Locations
8 sites in 3 countries. Site status is shown where the registry gives one.
Lucile Packard Children's Hospital
Palo Alto, California
Memorial Sloan Kettering Cancer Center
New York, New York
Duke University
Chapel Hill, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Texas Children's Hospital
Houston, Texas
University of Wisconsin Hospital and Clinics
Madison, Wisconsin
Children's Hospital at Westmead
Westmead, New South Wales, Australia
Hospital for Sick Children
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.